AVR

Anteris Technologies Global Corp.

Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Insider trades

Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Anteris Technologies Global Corp. develops transcatheter heart valve replacement technologies, including its DurAVR polymer-based valve designed to treat structural heart disease. The company focuses on devices for aortic valve replacement procedures intended to more closely mimic native valve function.

Industry

Orthopedic, Prosthetic & Surgical Appliances & Supplies

Headquarters

Eagan, MN

Exchange

Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

Insider	Type	Value	Shares / Price	Date
L1 Capital Pty Ltd10% Owner	Buy	$2.45M	322,940at $7.60	Oct 1, 2026
L1 Capital Pty Ltd10% Owner	Buy	$573K	74,286at $7.72	Sep 30, 2026
L1 Capital Pty Ltd10% Owner	Sell	$3.50M	375,815at $9.30	Aug 11, 2026
L1 Capital Pty Ltd10% Owner	Sell	$2.29M	251,844at $9.10	Aug 10, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for AVR.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable AVR activity by email

Free alerts for the insider and congressional trades worth watching.

Email address

Mobile number (optional)

Leave mobile blank for email only. Outside US/Canada, include + and your country code.

By checking this box and submitting, I agree to receive recurring automated marketing text messages from MySmarTrend (Ramy LLC) at the mobile number provided, including market alerts, commentary, and offers for MySmarTrend products and subscriptions. Messages may begin when the SMS program launches. Message frequency varies. Message and data rates may apply. Consent is not a condition of purchase or email signup. Reply STOP to opt out or HELP for help once messaging begins. Before launch or at any time, contact privacy@mysmartrend.com to withdraw consent or get help. I agree to the SMS Terms and acknowledge the Privacy Policy.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.